Literature DB >> 29485944

The Effects of Viral Infection on Lymphocyte Metabolism: A New Perspective on Disease Characterization.

Thomas Dymond1.   

Abstract

Over the past decade, metabolic dysfunction has been re-examined as an area of interest in a variety of atopic, malignant, and autoimmune conditions. The unique immune and, specifically, lymphocyte metabolic dysfunctions in disease are starting to be more clearly classified. Exploring the lymphocyte metabolic profiles of these diseases in the current literature, we characterize these diseases into two distinct metabolic groups. The influence of viral infection on immune metabolic dysfunction is explored. During an acute or chronic infection, there is a varied rapid shift in nutrients available to immune cells. This article explores the effect of these changes in nutrient availability and the resulting outcome on immune cell function. From this, a new hypothesis is proposed that these two groups of conditions, characterized by two unique immune profiles, are caused by either acute or chronic viral infections. The physiology behind this is explored, which proposes a new step between a healthy immune system and that of disease, in a unique working model.

Entities:  

Keywords:  disease; immunometabolism; infection; lymphocyte; metabolism

Mesh:

Substances:

Year:  2018        PMID: 29485944     DOI: 10.1089/vim.2017.0194

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  3 in total

1.  A Novel Scoring System for Prediction of Disease Severity in COVID-19.

Authors:  Chi Zhang; Ling Qin; Kang Li; Qi Wang; Yan Zhao; Bin Xu; Lianchun Liang; Yanchao Dai; Yingmei Feng; Jianping Sun; Xuemei Li; Zhongjie Hu; Haiping Xiang; Tao Dong; Ronghua Jin; Yonghong Zhang
Journal:  Front Cell Infect Microbiol       Date:  2020-06-05       Impact factor: 5.293

2.  Lymphopenia and Early Variation of Lymphocytes to Predict In-Hospital Mortality and Severity in ED Patients with SARS-CoV-2 Infection.

Authors:  Maxence Simon; Pierrick Le Borgne; François Lefevbre; Sylvie Chabrier; Lauriane Cipolat; Aline Remillon; Florent Baicry; Pascal Bilbault; Charles-Eric Lavoignet; Laure Abensur Vuillaume
Journal:  J Clin Med       Date:  2022-03-24       Impact factor: 4.241

3.  The impact of charlson comorbidity index on mortality from SARS-CoV-2 virus infection and A novel COVID-19 mortality index: CoLACD.

Authors:  Yelda Varol; Burcin Hakoglu; Ali Kadri Cirak; Gulru Polat; Berna Komurcuoglu; Berrin Akkol; Cagri Atasoy; Eda Bayramic; Gunseli Balci; Sena Ataman; Sinem Ermin; Enver Yalniz
Journal:  Int J Clin Pract       Date:  2020-12-07       Impact factor: 3.149

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.